MEDarchon

Nashville, United States Founded: 2012 • Age: 14 yrs Acquired By XSOLIS
Mobile-based care coordination system for hospitals and clinics along with analytics to predict patients at risk.

About MEDarchon

MEDarchon is a Healthcare company based in Nashville (United States) founded in 2012, and was acquired by XSOLIS in November 2019. Mobile-based care coordination system for hospitals and clinics along with analytics to predict patients at risk. MEDarchon has raised $1.83 million across 2 funding rounds from investors including XSOLIS, West End Holdings and Nuecura Partners. MEDarchon offers products and services including Slotfb Platform. Its focus areas include HealthTech, Healthcare IT, Horizontal and Communication Solutions. Its competitors include Vocera, Spok and OptimizeRx; 1 of its 3 listed competitors has raised funding.

Company details

MEDarchon provides medical professionals a system to text through a secure smartphone application.The app determines whom to the message should go and with what urgency based on the issue and time of day. The requests get assigned to some other staff member if the message is not viewed in a certain amount. Also, they have a patented analytics system that helps identify when patients are at risk based on communication problems.

Key Metrics
  • Total Equity Funding
    $1.83M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.6M (USD), Seed

    Aug 2014

  • Investors
    XSOLIS

    & 2 more

  • Acquired by
    XSOLIS

    (Nov 2019)

Products & Services of MEDarchon

MEDarchon offers a comprehensive portfolio of products and services, including Slotfb Platform.

Slotfb Platform
Online Gaming

Platform for playing and registering slot games securely.

Funding Insights of MEDarchon

MEDarchon has successfully raised a total of $1.83M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.6 million completed in August 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.83M
  • Total Rounds 2
  • Last Round Seed β€” $1.6M
  • First Round $225,000

    (May 2013)

  • Investors Count 2

All 2 funding rounds of MEDarchon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2014$1.6MSeed––
May 2013$225,000Seed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in MEDarchon

MEDarchon has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include XSOLIS, West End Holdings and Nuecura Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
West End Holdings is engaged in private equity investments.
2012westendholdings.comNashville, United States
Healthcare investments are managed by Nuecura Partners.
nuecura.com
AI-based platform for physicians and payers to analyze denial management
2013xsolis.comNashville, United States
Premium access

Investor details for MEDarchon

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of MEDarchon

4 dated milestones of MEDarchon across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded MEDarchon is founded.
  2. Funding First funding round of $225K.
  3. Funding Latest funding round, Seed, of $1.6M.
  4. Exit Acquired by XSOLIS.

Competitors of MEDarchon

MEDarchon has 3 listed competitors in our database, 1 of them funded. They include Vocera, Spok and OptimizeRx.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
vocera.com2000San Jose, United States$47.9M145
Cloud-based messaging and workflow solutions are delivered for healthcare providers.
spok.com1984Fairfax, United States376
Secure messaging and clinical alerting solutions are provided for healthcare.
optimizerx.com2006Rochester, United States94
Cloud-based platform enables hospital point-of-care communication management.
Premium access

Detailed competitors of MEDarchon

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as MEDarchon (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Medarchon

Premium access

Complete news archive for MEDarchon

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MEDarchon

MEDarchon was founded in 2012 and raised its 1st funding round 1 year after it was founded.

MEDarchon is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.

MEDarchon is a funded company, having raised a total of $1.83M across 2 funding rounds to date. The company's 1st funding round was a Seed of $225K, raised on May 2013.

MEDarchon provides medical professionals a system to text through a secure smartphone application.The app determines whom to the message should go and with what urgency based on the issue and time of day. The requests get assigned to some other staff member if the message is not viewed in a certain amount. Also, they have a patented analytics system that helps identify when patients are at risk based on communication problems.

MEDarchon's top competitors include Vocera, OptimizeRx and Spok.

MEDarchon offers Slotfb Platform.

MEDarchon has 3 investors. Key investors include XSOLIS, West End Holdings, and Nuecura Partners.

Yes. MEDarchon was acquired by XSOLIS in November 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available